Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Kenneth I Ataga · Sankore

Kenneth I Ataga

ORCID, self-asserted

ORCID 0000-0002-4501-9982

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

5

Citations

63

h-index

3

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

2

Publications

4 works in the graph, newest first.

Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial
2025The Lancet HaematologyJournal27 citations10.1016/s2352-3026(24)00384-3
Safety profile of crizanlizumab 5.0 mg/kg in sickle cell disease: pooled data from clinical trials
2025Journal of sickle cell disease.JournalOpen accessSenior author0 citations10.1093/jscdis/yoaf036
Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
2023BMC Health Services ResearchJournalOpen accessSenior author8 citations10.1186/s12913-023-09984-6
P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY
2022HemaSphereJournalOpen accessSenior author0 citations10.1097/01.hs9.0000872916.50939.2e